Alps Dx has filed a notice of an exempt offering of securities to raise $3,250,000.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Alps Dx is raising up to $3,250,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Alps Dx
Alps Dx is a diagnostics tooling and automation company focused on improving the speed, safety, and scalability of oral fluid drug testing and related pre-analytical workflows. The company says its mission is to help laboratories of all sizes adopt automation without requiring capital investments, positioning its technology as accessible to a wide range of lab customers. Its platform is built around end-to-end processing, from sample collection through pre-analytical testing, with an emphasis on modernizing oral fluid workflows. Alps Dx also develops connected technologies, including purpose-built instruments, consumables, workflow software, and applications designed to improve operational continuity and efficiency. The company launched in 2026 and describes itself as dedicated to transforming the oral fluid continuum for drug screening and beyond, with headquarters in Richmond, Virginia.
To learn more, visit https://alpsdx.com/
LinkedIn: https://www.linkedin.com/company/alps-dx
Contact:
Ali Safavi, Chief Executive Officer
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.